NUVL earnings: next report 2026-08-06, real EPS beat/miss history, analyst consensus Hold, P/E -20.46. Updated 2026-07-23.
Nuvalent (NUVL) Research Hub
Nuvalent (NUVL) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-07-20, shares last closed at 123.96 USD (0.00%), in a uptrend — price above rising 50-DMA, 50-DMA above 200-DMA. Valuation: trailing P/E -20.46, market cap 9.13B. This hub links to the full technical, earnings and options research available for NUVL.
Last updated 2026-07-20 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 123.96 USD (0.00%) |
| 52-week range | 71.13 USD – 123.99 USD |
| Trend regime | Uptrend |
| 14-day RSI | 95.9 (Overbought) |
| Trailing P/E | -20.46 |
| Market cap | 9.13B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for NUVL
Covered Call on NUVL: how it works, illustrative setup around the real 123.96 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on NUVL: how it works, illustrative setup around the real 123.96 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on NUVL: how it works, illustrative setup around the real 123.96 USD price, max profit/loss, breakeven and when to use it. Educational.
NUVL technical analysis: uptrend, last 123.96 USD, RSI 95.9, 52w range 71.13 USD–123.99 USD, real support/resistance. Updated 2026-07-20.
Frequently asked questions
What sector is NUVL in?
Nuvalent (NUVL) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is NUVL in an uptrend or downtrend?
As of 2026-07-20, NUVL is in a uptrend — price above rising 50-DMA, 50-DMA above 200-DMA. See the full technical research page for support and resistance levels.
What is NUVL's trailing P/E ratio?
NUVL's trailing P/E is -20.46, with a market cap of 9.13B. See the earnings research page for full valuation detail.
When does NUVL next report earnings?
NUVL is next scheduled to report earnings on 2026-08-06, with a consensus EPS estimate of -1.44 USD.